Effects of inhaled ipratropium bromide on breathing mechanics and gas exchange in exercising horses with chronic obstructive pulmonary disease.
Authors: Bayly W M, Duvivier D H, Votion D, Vandenput S, Art T, Lekeux P
Journal: Equine veterinary journal
Summary
Ipratropium bromide, an anticholinergic bronchodilator administered via inhalation prior to exercise, has shown promise in managing airway obstruction in horses with chronic obstructive pulmonary disease (COPD), yet its practical benefit during work remains unclear. Bayly and colleagues examined six Warmblood horses with acute COPD exacerbations using a randomised cross-over design, measuring pulmonary mechanics, arterial blood gases, oxygen consumption and exercise capacity following either 2,400 micrograms of ipratropium bromide or placebo powder 30 minutes before an incremental exercise test. The drug successfully reduced total pulmonary resistance and peak intrapleural pressure changes at rest, and lowered maximum intrapleural pressure during exercise at speeds of 8–10 m/s, indicating improved respiratory mechanics; however, these improvements did not translate to measurable gains in oxygen consumption, arterial blood gas values, time to fatigue or other functional breathing variables. For equine practitioners, this suggests that whilst ipratropium bromide may reduce the mechanical work of breathing in resting horses with COPD, its clinical value in enhancing exercise performance remains unproven—a finding that should inform treatment expectations and highlight the need for more effective therapeutic strategies to improve working capacity in affected animals.
Read the full abstract on PubMed
Practical Takeaways
- •While inhaled ipratropium bromide improves resting breathing mechanics in COPD horses, it does not translate to improved exercise performance or fatigue resistance
- •Pre-exercise inhalation of ipratropium bromide is not recommended as a performance-enhancing intervention for COPD-affected horses, despite theoretical benefits
- •Alternative or additional therapeutic approaches beyond anticholinergic bronchodilators should be considered to improve exercise capacity in horses with COPD
Key Findings
- •Inhaled ipratropium bromide reduced total pulmonary resistance and maximum intrapleural pressure changes before exercise in COPD-affected horses
- •Ipratropium bromide improved dynamic compliance prior to exercise testing
- •Despite improvements in breathing mechanics at rest, ipratropium bromide had no significant effect on oxygen consumption, blood gases, time to fatigue, or exercise capacity during incremental exercise
- •Exercise itself caused marked decrease in pulmonary resistance in placebo-treated horses but not in ipratropium bromide-treated horses